These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17506310)

  • 41. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical aspect of recent progress in phosphate metabolism. FGF23; physiological action and molecular mechanism in the regulation of phosphate and vitamin D metabolism].
    Shimada T
    Clin Calcium; 2009 Jun; 19(6):794-801. PubMed ID: 19483273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Osteomalacia: new aspects of pathogenesis and treatment].
    Burckhardt P
    Schweiz Med Wochenschr; 1973 Jul; 103(30):1053-6. PubMed ID: 4719056
    [No Abstract]   [Full Text] [Related]  

  • 45. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.
    Perwad F; Zhang MY; Tenenhouse HS; Portale AA
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1577-83. PubMed ID: 17699549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
    Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Progress in diagnosis and therapy: Calcium-phosphorus metabolism disorders].
    Ogata E
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):653-5. PubMed ID: 17506299
    [No Abstract]   [Full Text] [Related]  

  • 48. Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.
    Salanova Villanueva L; Sánchez González C; Sánchez Tomero JA; Aguilera A; Ortega Junco E
    Nefrologia; 2016; 36(4):368-75. PubMed ID: 27118192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vitamin D and collagen of bone tissue (review)].
    Spirichev VB; Isaeva VA
    Vopr Med Khim; 1984; 30(2):5-17. PubMed ID: 6377686
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
    Shimizu Y; Fukumoto S
    Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phosphatonin].
    Endo I; Matsumoto T
    Clin Calcium; 2007 Oct; 17(10):1580-4. PubMed ID: 17906412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of familial vitamin D-resistant rickets.
    Williams TF
    Ann Intern Med; 1968 Mar; 68(3):706-7. PubMed ID: 5643687
    [No Abstract]   [Full Text] [Related]  

  • 54. [Regulation and disorders of calcium and phosphate metabolism].
    Michigami T
    Clin Calcium; 2014 Feb; 24(2):169-75. PubMed ID: 24473349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of abnormal vitamin D metabolism in X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK
    Adv Exp Med Biol; 1984; 178():399-404. PubMed ID: 6542302
    [No Abstract]   [Full Text] [Related]  

  • 56. [Vitamin D and phosphate metabolism; relationship with aging-regulating gene].
    Taketani Y; Yamamoto H; Takeda E; Miyamoto K
    Clin Calcium; 2006 Jul; 16(7):1137-42. PubMed ID: 16816473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibroblast growth factor-23 and phosphorus metabolism.
    Tiosano D
    Endocr Dev; 2011; 21():67-77. PubMed ID: 21865755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hormones and osteoporosis update. FGF23/Klotho and bone metabolism].
    Fukumoto S
    Clin Calcium; 2009 Jul; 19(7):945-50. PubMed ID: 19567989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
    Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
    J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.